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Modulation of Tumor Promotion in Liver
Carcinogenesis
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Earlier, we demonstrated that feeding to rats a diet devoid of choline, a lipotropic factor, mark-
edly enhances hepatoma induction by several chemical carcinogens, and that the diet acts as a
strong promoter of the evolution of initiated cells to foci of altered hepatocytes. The ability of sev-
eral factors to modulate the action of the choline-devoid (CD) diet as a promoter was investigated by
quantitating the foci of y-glutamyl transpeptidase-positive hepatocytes developed in rats exposed to
a single injection of diethylnitrosamine. Addition to the diet of phenobarbital (PHB) resulted in a
promoting action stronger than those of the CD diet or of PHB alone. Two other barbiturates, amo-
barbital (AMB) and pentobarbital (PTB) exerted an effect similar to that of PHB, while barbituric
acid (BA) had no effect. In other studies, lowering the fat content of the CD diet reduced its efficacy
as a promotor, while the addition of a hypolipidemic agent, BR931, 4-chloro-642,3 xylidino)-2-pyri-
midinylthio (N-p-hydroxy-ethyl)acetamide, completely abolished the promoting action of the CD
diet. In rats not exposed to carcinogen, feeding the CD diet caused a marked enhancement of liver
DNA synthesis and of cell proliferation. Inclusion of PHB, PTB or AMB in the CD diet inhibited
these effects, while BA exerted no inhibition. The increased rate of DNA synthesis and cell prolifer-
ation in the liver were not affected by the level of fat in the CD diet. These results suggest that be-
side a stimulation of liver cell proliferation, other factor(s) determine the efficacy with which a CD
diet exerts its promoting action.
Introduction
Earlier, we demonstrated that feeding a diet de-
void of choline, a lipotropic factor, markedly en-
hanced liver tumor induction in rats by several
chemical carcinogens either included in the choline-
devoid (CD) diet or administered while rats were on
the CD diet (1-3). Further studies showed that
feeding the CD diet strongly promotes the evolution
of liver cells, initiated by chemical carcinogens, to
foci of y glutamyl transpeptidaseAGGT+ ) positive
hepatocytes (4) and the evolution of the foci to hepa-
tomas (5).
Thus, the action of a CD diet is very similar to
that of phenobarbital (PHB) which has been shown
to be also an effective promoter of liver carcinogen-
esis (6-9).
More recently, we found that inclusions of PHB
in a CD diet resulted in a synergistic effect of the
two agents (10). Indeed, in rats exposed to a single
injection of diethylnitrosamine (DEN), foci of GGT +
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hepatocytes developed in a number greater than
the sum of those observed in rats treated with
either agent alone. Studies on the mechanisms by
which certain agents modulate the efficacy of indi-
vidual promoting agents may become useful in ana-
lyzing the critical features of tumor promotion in
the liver. In this paper, we describe three other con-
ditions modulating the promoting action of a CD
diet, and present preliminary data on possible mech-
anisms underlying their action.
Materials and Methods
Male Sprague-Dawley rats (Zivic Miller Labora-
tories, Allison Park, PA) weighing 150-165 g were
used in all experiments. The animals were housed in
pairs in metal cages in a room with temperature,
humidity and light controls, and were given labora-
tory chow (Purina, Ralston Purina Co., St. Louis,
MO) and water ad libitum. Purified CD and choline
supplemented (CS) diets were prepared as previ-
ously described (11). These diets contain 14% fat. A
low-fat CD diet was prepared by reducing the levels
of corn oil and of Premix to 1 and 3%, respectively,SHINOZUKA ETAL.
while keeping the same relative proportions of the
other ingredients. PHB, pentobarbital (PTB) and
amobarbital (AMB) at a level of 0.06% and barbit-
uric acid (BA) at a level of 0.04% were incorporated
into the CD and CS diets at the expense of sucrose.
All agents were from Sigma Chemical, St. Louis,
MO. A hypolipidemic agent, 4-chloro-642,3-xylidi-
no)-2-pyridmidinylthio(N-p-hydroxyethyl)acetamide
(BR931) (LPB Instituto Farmaceutico, Milan) was
kindly supplied by Dr. J. Reddy, Northwestern Uni-
versity, Chicago, and was incorporated into the CS
and CD diets at a level of 0.2%.
For the assays of the induction of foci of GGT +
hepatocytes, rats were given a single intraperito-
neal injection of DEN (Aldrich Chemical Co., Madi-
son, WI) at doses of 40 or 50 mg/kg, 18 hr after a
partial hepatectomy, or of 160 mg/kg without a par-
tial hepatectomy. One week later, the animals were
divided into groups, each of which was fed one of
the experimental diets. The animals were sacrificed
4, 6 or 7 weeks thereafter, and liver sections were
prepared for quantitative of foci of GGT+ hepato-
cytes as previously described (4).
For determination of DNA synthesis, each animal
received a single IP dose of 50 ,CiI100 g body
weight of [3H]-thymidine (20 Ci/mmole, New
England Nuclear Corp. Boston, MA), 2 hr before
killing by decapitation. The liver was quickly ex-
cised, rinsed in cold saline, blotted dry, weighed,
and a 10% homogenate was immediately prepared
in cold 0.6 N percholoric acid (PCA). DNA was selec-
tively hydrolyzed, and radioactivity was determined
as previously described (12).
For counting the number of mitosis, blocks of
liver were fixed in a Stieve's solution, and 6 jim
thick sections were stained with hematoxylin and
eosin. Entire sections of the right and left lobes
were examined at a 400 x magnification, and hepa-
tocytes in mitosis were counted. The surface area of
the sections was calculated with the aid of a planim-
eter, and the number of mitosis per square centi-
meter of section were calculated. The results of all
experiments were evaluated statistically by Stu-
dent's t test, and differences between means were
regarded as significant ifp<0.05.
Results
Table 1 summarizes the results obtained in two
separate experiments in which barbiturates were
tested for their ability to promote the evolution of
liver cells, initiated with a single injection of DEN,
to foci ofGGT + hepatocytes. PHB, PTB, and AMB,
added to the CS diet, exhibited a comparable de-
gree of promotion, but barbituric acid showed no
promoting action. In agreement with our earlier ob-
servation (10), addition of PHB to the CD diet re-
sulted in a synergistic effect in as much as the num-
ber of foci was greater than the sum of those ob-
served in rats treated with the CD diet alone or the
CS + PHB diet. Addition of PTB to the CD diet
also resulted in a synergistic effect, while the combi-
nation of AMB and CD diet showed only an additive
effect. On the other hand, inclusion of BA in the CD
diet resulted in no increase in the promoting action
of the CD diet.
The effect of varying the fat content of the CD
diet was next investigated. As shown in Table 2,
the number of foci observed after 4 and 6 weeks of
feeding the high-fat CD diet was significantly higher
Table 1. Effect of barbiturates on the induction of GGT-positive foci in the liver.
Experiment and dieta No. foci/cm2b Diameter,,um
I CS 1.56± 1.1 156.3± 6.3
CS + amobarbital 11.4±3.3* 159.1± 6.1
CS + pentobarbital 13.4 ± 1.6* 160.4 ± 5.2
CS + phenobarbital 14.1 ± 2.3* 163.7 ± 6.3
CD 10.4 ± 1.0 239.9 ± 14.6
CD + amobarbital 23.5 ± 2.5**t 307.4 ± 17.4t
CD + pentobarbital 42.7 ± 7.6**t 362.8 ± 27.5t
CD + phenobarbital 35.4 ± 3.9**t 293.3 ± 16.0t
II CS 0.6 ± 0.4 188.6 ± 17.8
CD 17.2 ± 3.0 323.9 ± 19.1
CS + barbituric acid 0.9± 0.4 158.6± 5.1
CD + barbituric acid 22.7 ± 2.8 293.4± 10.1
a In both experiments, rats were initiated with a single injection of DEN (40 mg/kg), 18 hr after a partial hepatectomy. In ex-
periment I the rats were killed after 6 weeks of the dietary promotion, and in experiment II after 7 weeks.
b Each figure represents the mean ± SE of four to six rats.
* p<0.01 against the CS group.
**p<0.01 against the CD group.
t <0.05 against the CD group.
t <0.05 against the CD group andp<0.01 against the corresponding CS groups.
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Table 2. Induction of GGT + foci in the liver of rats fed high or low fat CD diet.a
Promotion Time, weeks Body weight, gb Liver weight, gb No. of foci/cm2b Size, mmb
CD-high fat 4 302.8 + 14.8 16.4 + 1.0 17.7 ± 6.4 250 + 18
CD-low fat 4 297.6 ± 6.3 17.2 ± 1.9 7.7 ± 3.1 223 ± 16
CD-high fat 6 392 ± 19.5 22.0 + 1.6 27.4 ± 4.2 358 + 54
CD-low fat 6 413 ± 20.0 23.8 ± 1.8 15.8 ± 2.5 236 ± 15
aRats were initiated with a single injection of DEN (50 mg/kg) 18 hr after a partial hepatectomy. Promotion was started 1 week
after initiation, and rats were killed 4 and 6 weeks thereafter.
bEach figure represents the mean ± SE of five rats.
Table 3. Effect of BR931 [4-chloro-642,3-xylidino)2-
pyrimidinylthio4N-Vf-hydroxyethyl)acetamide] in the induction
of GGT+ foci in the liver.
No. of foci/cma
4 weeks 6 weeks
Initiationa Promotionb promotion promotion
Saline CS + BR931 0 0
Saline CD+ BR931 0 0
DEN CS 1.3 ± 0.6 0.3 ± 0.2
DEN CD 6.9 ± 1.5 16.1 ± 4.0
DEN CS + BR931 0 0
DEN CD + BR931 0 0
a Rats were initiated with a single injection of DEN (160
mg/kg). Each group consists of seven or eight rats.
bPromotion was started 1 week after the initiation.
than that after feeding the low fat CD diet. At
each point, body and liver weights of the animals
showed no difference between the two groups.
The effect of BR 931 on the induction of foci of
GGT-positive hepatocytes was examined in rats ini-
tiated with a single injection of DEN (160 mg/kg)
without a prior partial hepatectomy (Table 3). After
4 and 6 weeks of dietary promotion, BR 931, added
to the CD diet completely abolished the promoting
action ofthe CD diet.
Earlier we demonstrated that feeding a CD diet
to rats causes an increase of liver DNA synthesis
and of cell proliferation (hepatocyte mitosis) over
those present in rats fed the CS diet, and that inclu-
sion of PHB in the CD diet inhibits such a stimula-
tion (12, 13).
The effects of other barbiturates included in the
diet on the stimulation of liver DNA synthesis and
liver cell proliferation induced by the CD diet were
investigated, and the results are shown in Figures 1
and 2. PTB inhibited DNA synthesis and cell pro-
liferation, and the degree of inhibition was compar-
able to that exerted by PHB. AMB, as judged by
mitotic counts, showed a lesser degree of inhibition
(Fig. 2), and BA had no significant effect on the CD
diet-induced stimulation of DNA synthesis and cell
proliferation.
Comparative studies of the rate of liver DNA
synthesis and cell proliferation in rats fed a high or
low fat CD diet were also performed, and the re-
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FIGURE 1. Effect of feeding for 1 week a choline-
supplemented (CS) or choline-devoid (CD) diet and the
same diets containing 0.06% pentobarbital (PTB) or 0.04%
barbituric acid (BA) on incorporation of 3H-thymidine into
liver DNA. Four rats in each group received a single IP
dose of 3H-thymidine, 50 jACi/100 g body weight, 2 hr before
killing by decapitation. The radioactivity in DNA was
determined as described in the text and the results are
expressed as mean % ± SE of control (CS or CD) value;
p<0.05 between the CD and CD + PTB.
sults are shown in Table 4. Comparable levels of
DNA synthesis and cell proliferation were observed
in rats fed the high and low fat CD diets for 1 and 2
weeks, but the levels were significantly higher than
those present in the liver of rats fed a CS diet.
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Discussion
Experimental studies of liver carcinogenesis have
recently confirmed the validity of the concept of a
two stage development of hepatomas, and a grow-
ing number of promoters of liver carcinogenesis
have been identified in the past few years (14). How-
ever, the nature of and the mechanism underlying
tumor promotion in the liver are poorly understood.
In our laboratory, we have developed a dietary
means of promotion of hepatoma induction in rats,
namely feeding a diet devoid of choline (4, 5).
The present study demonstrates three conditions
which modulate the promoting efficacy of the CD
diet, one being stimulatory and the others being
either partially or completely inhibitory. Analysis of
the mechanism of action of these modulated sys-
tems may assist in elucidating the critical features
of tumor promotion in the liver.
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FIGURE 2. Effect of feeding for 1 week a choline-devoid (CD)
diet or the CD diet containing 0.06% phenobarbital (PHB),
pentobarbital (PTB), amobarbital (AMB) or 0.04% barbi-
turic acid (BA) on the number of hepatocytes in mitosis.
Mitoses were counted on hematoxylin eosin-stained liver
sections of each animal at a 400 x magnification, and the
number of mitoses/cm2 of section was calculated. The
results are expressed as % of CD mean value + SE of
four rats. p<0.01 = CD vs CD + PHB, CD + PTB, CD +
DTB and CD + AMB; p<0.01 = CD + AMB vs. CD +
PHB and CD + PTB.
As a step toward achieving this goal, we studied
and compared the three conditions as promoters of
the emergence of foci of altered hepatocytes, and
their effects on liver cell DNA synthesis and cell
proliferation. Using three structurally related barbi-
turates, we confirmed and extended our earlier ob-
servations that inclusion of PHB into a CD diet
markedly enhances the promotion action of the diet
(10).
PTB and AMB, when added to the CS diet, were
shown to be effective in promoting the evolution of
initiated cells to foci of GGT-positive hepatocytes.
However, BA, at a level equimolar to the other bar-
biturates, had no promoting effect. These findings
indicate that the promoting activity of barbiturates
is dependent on biological effects due to the pres-
ence of different alkyl groups at the C-5 position of
BA. As in the case of PHB, inclusion of PTB or
AMB into the CD diet resulted in an enhanced pro-
moting activity, though the former exerted a
stronger enhancement than the latter. It is of inter-
est to note that the degree of stimulation of promo-
tion correlates in part with the degree with which
these barbiturates inhibit the CD diet-induced
DNA synthesis and cell proliferation in the liver.
Indeed, PTB inhibited DNA synthesis and cell pro-
liferation as effectively as PHB, while AMB, as
judged by mitotic counts, showed a lesser degree of
inhibition. BA, on the other hand, had no significant
effects on either DNA synthesis and cell prolifera-
tion or promotion. These observations support our
earlier suggestion that the suppression of cell
growth of the noninitiated population of cells in an
initiated liver may result in a selective growth stim-
ulation of the initiated cells, though direct evidence
is lacking (13).
The results obtained with CD diets containing a
high or low level of fat, are consistent with a num-
Table 4. Liver DNA synthesis and hepatocyte mitosis
in rats fed high fat-CS, high fat-CD or low fat-CD diet.
Time on
diet,
3H-Thd
incorporation,
Hepatocyte
mitosis, no. of
hepatocytes/cm2
Diet weeks, dpm/m,ug DNAb livera,b
CS-high fat 1 71.1 12.6b 6.1 ± 3.4
CD-high fat 1 361.0 ± 114.8* 70.7 ± 10.6*
CD-low fat 1 335.0 ± 27.7* 60.8 ± 12.9
CS-high fat 2 76.3 ± 42.2 1.7 ± 1.7
CD-high fat 2 142.1 ± 67.6** 36.4 ± 6.8*
CD-low fat 2 160.3 ± 33.8** 52.8 ± 12.5*
aNumber of hepatocytes in mitosis per square centimeter of
liver sections.
bEach figure represents the mean ± SE of three or four
rats.
*p<0.01 against the CS group.
**p<0.05 against the CS group.
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ber of observations in literature that a high fat con-
tent in the diet has a general enhancing effect on
the development of spontaneous tumors, as well as
on the induction of tumors by chemicals in experi-
mental animals (15, 16).
Using a combined lipotrope-deficient diet, Rogers
and her associates have demonstrated that the high
fat content in the diet markedly enhances hepato-
carcinogenesis by a variety of carcinogens (17, 18).
Even though the role played in tumor promotion by
both quantity and quality of dietary fat appears to
be complex, it was of interest to find in the present
study that there is no correlation between efficacy
of the promotion and degree of stimulation of liver
cells proliferation with CD diets containing different
amounts of fat. Enhanced liver cell proliferation in-
duced by a partial hepatectomy or a necrogenic
dose of carbon tetrachloride has been shown to ac-
celerate the development of liver tumors in rats or
mice initiated with a variety of carcinogens (19-22).
However, our findings suggest that the general
properties of enhanced cell proliferation per se are
not the sole factors in determining the efficacy of
tumor promotion in the liver and that other factors
must be involved.
The apparent lack of the promoting activity by
BR 931, as assayed in our test system, is of consid-
erable interest. BR 931, one of many hypolipidemic
agents which stimulate microbody proliferation in
the liver and induce hepatomegaly, has been shown
to induce hepatomas in rats and mice after long
term administration (23). In our system, RB 931
showed no promoting activity when added to the
CS diet, and completely abolished the promoting ac-
tivity of the CD diet. As many other hypolipidemic
agents, BR 931 has been shown to stimulate liver
cell proliferation without inducing cells necrosis (24).
Although we have not yet analyzed cell prolifera-
tion kinetics in the liver of rats fed BR 931 with our
dietary regimens, this agent appears to provide a
unique situation in which stimulation of liver cell
proliferation may not promote the evolution of initi-
ated cells to foci of GGT positive hepatocytes. Obvi-
ously, further studies are needed to answer this in-
triguing question.
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